Rocket Lab Shed 25% Over 3 Months: 150% Returns Sure to Come According to This Wall Street Pro
Rocket Lab (RKLB) shares fell 25% over 3 months after delaying Neutron rocket launch to 2027. Analysts see 94% upside to $102.15 target, with some predicting 147%. The company has a $2.36B backlog, defense contracts, and pending Iridium acquisition. Earnings missed estimates, and dilution concerns persist.
How this was made
The 30-second read
Why it matters
The launch delay has already caused a 14% intraday drop and a 25% decline over three months, raising concerns about cash burn and dilution.
Market read
The news directly moves RKLB and may influence peer space stocks, but broader market impact is limited.
What to watch
The $816M Space Development Agency contract and Iridium acquisition could offset delay concerns over the longer term.
Background
Rocket Lab is a commercial launch provider developing the reusable Neutron medium‑lift rocket and recently secured a $816M defense contract.
Ticker impact
Rocket Lab announced its Neutron rocket first launch slipped to 2027, triggering a 14% intraday drop and a 25% decline over three months.
likely further downside until launch timeline is clarified
The launch delay is a fresh catalyst that directly caused a sharp sell‑off; investors may continue to sell on heightened risk.
Market effects
Space launch sector may see broader pressure as peers' valuations are tied to schedule certainty.
U.S. small‑cap space stocks could face short‑term weakness.
Limited to investors focused on commercial launch providers.
Counterpoint
If Neutron eventually launches on schedule, the stock could rebound sharply on upside potential.
Key entities
- CompanyRocket Lab
U.S.-listed space launch provider (NASDAQ:RKLB).
